Advisory Committee on Prescription Medicines (ACPM)
Role of the ACPM
The Advisory Committee on Prescription Medicines (ACPM) was formed in January 2010. The ACPM advises and makes recommendations to the TGA on prescription medicines. This includes:
- inclusion of a prescription medicine on the Australian Register of Therapeutic Goods (the Register)
- changes to an entry of a prescription medicine on the Register
- removal or retention of a prescription medicine on the Register.
ACPM may also provide advice to the Minister or the Secretary, through the TGA on other matters concerning a prescription medicine, and any other matters referred to it by the Minister or the Secretary.
The ACPM is the successor of the Australian Drug Evaluation Committee (ADEC), which was formed in 1963.
Clinical Associate Professor Geoffrey Herkes is Head of Department of Neurology, Royal North Shore Hospital Sydney, and holds a teaching position at the University of Sydney. He has major research interests in neuropharmacology and epilepsy, as well as in general neurology. He attained his PhD at the University of Queensland and studied at the Mayo Clinic, USA. Associate Professor Herkes has held executive positions on many research and clinical associations and bodies within Australia. He has been a member of ACPM since 1999, and was appointed Chair in 2008. Associate Professor Herkes provides expertise in the field of neurology.
- Professor Allen Cheng is an infectious diseases physician at the Alfred Hospital and Associate Chair in Infectious Diseases Epidemiology at the Department of Epidemiology and Preventative Medicine at Monash University. Dr Cheng has diverse clinical experience in metropolitan and regional hospitals in Australia, research interests in clinical infectious diseases, infection control and public health epidemiology. Professor Cheng provides expertise in the fields of infectious diseases and biostatistics.
- Professor Stewart Kellie is a paediatric oncologist at The Children's Hospital, Westmead and Clinical Professor in the Discipline of Paediatrics and Child Health at the University of Sydney. He has a particular interest in neuro-oncology in infants and children and has an MD for his thesis titled 'Advances in Paediatric Neuro-Oncology'. He has an ongoing interest in training fellows from developing countries. Professor Kellie provides expertise in the fields of oncology and paediatrics.
- Professor Harry McConnell is a neuropsychiatrist with specific expertise in neurodisability and epilepsy, with broad international experience. Professor McConnell is currently Director of Neurosciences at St Vincent's Hospital Brisbane and the Clinical Subdean at Gold Coast University Hospital and Griffith University School of Medicine where he is also Professor of Neuropsychiatry and Neurodisability. He is Chair of the South East Queensland Disability Advisory Council and a member of the Queensland Disability Advisory Council. Professor McConnell provides expertise in the field of psychiatry.
- Associate Professor Julian McNeil is Head of Service, Medicine at Modbury Hospital and Rheumatology for the Northern Adelaide Local Health Network. He has chaired Therapeutics Committee of the Australian Rheumatology Association for the past two years and continues as a member and has previously chaired the Modbury Hospital institutional ethics committee for 10 years. Associate Professor McNeil has research experience in the fields of connective tissue biochemistry and the musculoskeletal manifestation of diabetes. Associate Professor McNeil provides expertise in the field of rheumatology.
- Associate Professor Anne Mijch OAM is a consultant infectious diseases specialist with special interest in HIV, STIs and Hepatitis. She established HIV services at Fairfield Infectious Diseases Hospital then transferred these to Alfred Hospital in Melbourne as Head of Victorian HIV Service. Associate Professor Mijch has been recognised for her work in HIV/AIDS and was awarded the Medal of the Order of Australia for her services to medicine in this field. She is now working as Consultant and Mentor in Infectious Diseases and HIV in SE Asia and Oceania, as Adjunct Professor at Monash University and as a Senior Principal Fellow within the Burnet Institute. Associate Professor Mijch provides expertise in the field of infectious diseases.
- Dr Stephen Phillips OAM is a General Practitioner with long interest in standards and quality, particularly in relation to medicines, therapeutics and public health. Dr Phillips actively participates on a variety of committees and medical professional organisations. He was awarded the Medal of the Order of Australia for his services as a promoter of the safe and effective use of medicines. Dr Phillips provides expertise in the field of general medical practice.
- Associate Professor Peter Pillans is a specialist in clinical pharmacology, Associate Professor in the Department of Medicine, University of Queensland and currently the Director of Clinical Pharmacology and a specialist physician at Princess Alexandra Hospital. He has a particular interest in drug safety and served on the New Zealand Medicines Adverse Reactions Committee and the Australian Adverse Drug Reactions Advisory Committee for many years. He chairs numerous hospital drug committees and is deputy chair of the Queensland Hospitals Medicines Advisory Committee. Associate Professor Pillans provides expertise in the fields of clinical pharmacology and pharmaceutical chemistry.
- Dr John Riley is the Head of Department of Gastroenterology, Royal North Shore Hospital, Sydney and also holds a teaching position at the University of Sydney. He has a Doctorate of Medicine from the University of Sydney based on research carried out at Columbia Medical Centre, New York, USA. Dr Riley has been an active member of the Gastroenterology Department at Royal North Shore Hospital for many years. Having a particular interest in small bowel disease, inflammatory bowel disease and endoscopy, Dr Riley provides expertise in the field of gastroenterology and hepatology.
- Associate Professor Philip Robinson is a specialist paediatric respiratory physician at the Royal Children's Hospital, Victoria and head of the hospital's Cystic Fibrosis Service. Associate professor Robinson provides expertise in the fields of respiratory disease and paediatrics.
- Associate Professor David Smallwood is a specialist adult respiratory physician at the Royal Melbourne Hospital and has a PhD on airway remodelling in asthma. He has also undertaken extensive research into chronic obstructive pulmonary disease. Associate Professor Smallwood has experience in cardiac respiratory medicine and pulmonary hypertension. Associate Professor Smallwood provides expertise in the field of respiratory disease.
- Dr Kee Meng Tan is a consultant neurologist trained at Royal Brisbane & Women's Hospital and Mayo Clinic (USA), with specific expertise in epilepsy and autoimmune neurological disease. He is currently a member of The Royal Melbourne Hospital's comprehensive epilepsy program and is engaged in research into inflammatory aspects of epilepsy. Dr Tan provides expertise in the field of neurology.
- Professor Duncan Topliss is the Director of the Department of Endocrinology and Diabetes at the Alfred Hospital, Melbourne, and a Professor of Medicine in the Department of Medicine, Monash University. He is a past-President and Life Member of the Endocrine Society of Australia. He has been an investigator on multiple major international diabetes and thyroid cancer trials. He has a wide expertise in clinical endocrinology including in osteoporosis, pituitary and adrenal disease, and endocrine hypertension. Professor Topliss provides expertise in the fields of endocrinology & pharmacokinetics.
- Associate Professor Beverley Vollenhoven is a gynaecologist and holds a teaching position in the Department of Obstetrics and Gynaecology, Monash University and is Director of Gynaecology, Southern Health, Melbourne. She is also a reproductive endocrinologist and infertility specialist and a clinician at Monash IVF. Associate Professor Vollenhoven provides expertise in the field of gynaecology/reproductive medicine.
- Professor John Ziegler AM is Head of the Department of Immunology and Infectious Diseases and of the HIV Service, Sydney Children's Hospital. His current research interests include genetics of primary immune deficiency disorders (PID), long term outcomes for children with PID; and severe food allergy in Australian children. Professor Ziegler is a Fellow of the Royal Australasian College of Physicians and cofounder of the Australasian Society for HIV Medicine. He also serves on NSW Department of Health Anaphylaxis Education Governing Group and chairs the Immunoglobulin User Group for NSW Health. Professor Ziegler provides expertise in the field of immunology.
ACPM meeting dates
|Meeting no.||Cut-off date for pre-ACPM response||Meeting date|
|2016/1 (308)||Tuesday 19 January 2016||Friday 5 February 2016|
|2016/2 (309)||Tuesday 15 March 2016||Friday 1 April 2016|
|2016/3 (310)||Tuesday 17 May 2016||Friday 3 June 2016|
|2016/4 (311)||Tuesday 19 July 2016||Friday 5 August 2016|
|2016/5 (312)||Tuesday 20 September 2016||Friday 7 October 2016|
|2016/6 (313)||Tuesday 15 November 2016||Friday 2 December 2016|
The ACPM Pharmaceutical Subcommittee (PSC)
The PSC makes recommendations to ACPM and the TGA on the pharmaceutical chemistry, quality control, bioavailability and pharmacokinetics of prescription medicines proposed for registration in Australia.
Professor Andrew McLachlan has expertise in clinical and experimental pharmacology. He is Professor of Pharmacy (Aged Care) in the Faculty of Pharmacy at the University of Sydney, and the Centre for Education and Research on Ageing at the Concord Repatriation General Hospital, NSW. Professor McLachlan's research interests include understanding the causes and consequences of variability in response to medicines and how this informs their quality use.
- Associate Professor Mary Collins is a specialist in medicinal chemistry and molecular pharmacology. She is Professor of Pharmaceutical Neuroscience in the Faculty of Pharmacy at the University of Sydney. Associate Professor Collins' research interests include medicinal chemistry and molecular pharmacology of GABA-A and nicotinic acetylcholine receptors. She has published approximately 100 refereed international publications, and is the recipient of a number of scientific awards for her research.
- Professor Andrew Davey is a specialist in pharmacokinetics and biopharmaceutics. He is the Head of the School of Pharmacy at Griffith University. Professor Davey has previously worked at the University of South Australia, Otago University, as a consultant to the Centre of Pharmaceutical Research and within community pharmacy. He has authored over 80 significant research publications including peer-reviewed research papers, industry reports and textbook chapters in the areas of pharmacokinetics, inflammation, pharmaceutical sciences, and education.
- Dr David Foster is a specialist in pharmacometrics and biopharmaceutics. He is a Senior Lecturer in pharmacokinetics in the School of Pharmacy and Medical Sciences at the University of South Australia. Dr Foster is a member of the Drug and Therapeutics Committee (Clinical Trial Group) of the Children, Youth and Women's Health Service, South Australia.
- Professor Beverley Glass is specialist in Pharmaceutical Chemistry. She is a recognised expert in Drug Stability, in particular Photostability, and is currently the Chair of Pharmacy in the College of Medicine and Dentistry at James Cook University. Professor Glass' main research interests centre on in-use drug stability and the impact of extreme environmental conditions of light, heat and humidity on the storage and use of medicines, to ensure their quality especially in the Tropics.
- Professor Jane Hanrahan is a specialist in pharmaceutical chemistry. She is a medicinal chemist in the Faculty of Pharmacy at the University of Sydney. Her research interests include the medicinal chemistry and pharmacology of neurologically active drugs and the isolation and identification of natural products with neurological and anti-cancer activities. Professor Hanrahan provides expertise in the field of pharmaceutical chemistry.
- Dr Stefanie Hennig is a specialist in clinical pharmacokinetics and pharmacodynamics. She is a Lecturer in the School of Pharmacy at the University of Queensland. Dr Hennig's research interests apply pharmacometric methods to improve dosing strategies and clinical outcomes using a model based analysis approach. Her research has led to improved dosing regimens for antimicrobial drugs, changed dosing guidelines and improved therapeutic drug monitoring procedures.
- Clinical Associate Professor Geoffrey Herkes is a specialist in neurology. He is a Clinical Associate Professor at the University of Sydney, former Head of the Department of Neurology at the Royal North Shore Hospital, and has a teaching position at the University of Sydney. He has a major research interest in neuropharmacology and epilepsy as well as in general neurology. He attained his PhD at the University of Queensland and studied at the Mayo Clinic, USA. Clinical Associate Professor Herkes has been a member of ACPM (previously ADEC) since 1999 and was appointed as the Chair in 2008.
- Professor Carl Kirkpatrick is a specialist in pharmacometrics and biopharmaceutics. He is the Director of the Centre for Medicine Use and Safety at Monash University. Professor Kirkpatrick is a councillor of the Australasian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT) and the secretary of the Population Approach Group in Australia and New Zealand.
- Professor Iqbal Ramzan is a specialist in drug pharmacokinetics and pharmacodynamics and biopharmaceutics. He is an international leader in pharmacy education and has published over 140 refereed papers. Professor Ramzan is the Director of the Council of Pharmacy Schools (Australia and New Zealand) and serves on the Accreditation Committee of the Australian Pharmacy Council. Professor Ramzan is a registered Pharmacist and holds a Diploma from the Australian Institute of Company Directors.
- Professor Michael Roberts is a specialist in biopharmaceutics and clinical pharmacokinetics. He is a Senior Principal Research Fellow of the National Health and Medical Research Council and Professor of Therapeutics and Pharmaceutical Science at the University of South Australia. As well as, Professor of Clinical Pharmacology and Therapeutics and Director of the Therapeutics Research Centre at the University of Queensland. Professor Roberts has published more than 430 peer-reviewed papers, and has received many awards.
- Dr Desmond B Williams is a specialist in pharmaceutical chemistry, biopharmaceutics and drug product assessment. He is the Program Director of Pharmaceutical Sciences at the University of South Australia. Dr Williams is a Fellow of the Royal Australian Chemical Institute, a Fellow of the Australian College of Pharmacy, and a member of the Examination Editorial Group, Australian Pharmacy Council, AusBiotech, the American Association of Pharmaceutical Scientists and the Australasian Pharmaceutical Science Association.
- Associate Professor Erica Wood is a specialist in transfusion medicine. She is a consultant haematologist at Monash Medical Centre in Melbourne, and an honorary consultant haematologist at the Peter MacCallum Cancer Centre. She is vice-president of the International Society of Blood Transfusion, president of the International Haemovigilance Network, and past-president of the Australian and New Zealand Society of Blood Transfusion. She is a member of the Victorian Blood Matters Programme Advisory Committee and its Serious Transfusion Incident Reporting haemovigilance program expert group.
PSC meeting dates
|Meeting no.||Meeting date|
|2016/1 (166)||Monday 25 January 2016|
|2016/2 (167)||Tuesday 22 March 2016|
|2016/3 (168)||Tuesday 24 May 2016|
|2016/4 (169)||Tuesday 26 July 2016|
|2016/5 (170)||Tuesday 27 September 2016|
|2016/6 (171)||Tuesday 22 November 2016|
Contacting the ACPM
To contact the ACPM Secretariat:
|Phone||+61 2 6232 8852|
|Fax||+61 2 6203 1250|
|Postal address||Advisory Committee on Prescription Medicines
Therapeutic Goods Administration PO Box 100
Woden ACT 2606